Skip to main content
. 2019 Feb 12;14(2):e0212053. doi: 10.1371/journal.pone.0212053

Fig 4. Interference with SLFN11 expression protects HAP1 from IFN-γ and DDA.

Fig 4

A-D) Parental HAP1 cells or three SLFN11 KO clones were exposed to the indicated concentrations of IFN-γ (A), cisplatin (B), doxorubicin (C), or docetaxel (D). 48 hours after IFN-γ or chemotherapy exposure, cell viability was assayed by analysis of metabolic activity. * p<0.05, ** p<0.01, *** p<0.001.